✦ LIBER ✦

Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases

✍ Scribed by Lucinda Billingham,Emma Hall,Clare Cruickshank,Jim Barber,Steve Nicholson

Book ID: 126377154
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 120 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-S1-O58

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Bayesian Approach to Surrogacy Assessm

A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials

✍ Yun Li; Jeremy M.G. Taylor; Michael R. Elliott 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

Utilizing Focus Groups with Potential Pa

Utilizing Focus Groups with Potential Participants and Their Parents: An Approach to Inform Study Design in a Large Clinical Trial

✍ Kadimpati, Sandeep; McCormick, Jennifer B.; Chiu, Yichen; Parker, Ashley B.; Ift 📂 Article 📅 2014 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 117 KB

Are accelerometers a useful tool for mea

Are accelerometers a useful tool for measuring disease activity in children with eczema? Validity, responsiveness to change, and acceptability of use in a clinical trial setting

✍ C.I. Wootton; K. Koller; S. Lawton; C. O’Leary; K.S. Thomas; on behalf of the SW 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

207 A Novel Algorithm-Based Approach Usi

207 A Novel Algorithm-Based Approach Using Clinical Parameters, Genetic and Serological Markers to Effectively Predict Aggressive Disease Behavior in Patients With Crohn's Disease

✍ Gary Lichtenstein; Derren M. Barken; Leonard Eggleston; Fred Princen; Michelle P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Application of Clinical Trial Simulation

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

✍ Peter Lockwood; Wayne Ewy; David Hermann; Nick Holford 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 353 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB